1. Home
  2. NEO vs ELME Comparison

NEO vs ELME Comparison

Compare NEO & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • ELME
  • Stock Information
  • Founded
  • NEO 2001
  • ELME 1960
  • Country
  • NEO United States
  • ELME United States
  • Employees
  • NEO N/A
  • ELME N/A
  • Industry
  • NEO Precision Instruments
  • ELME Real Estate Investment Trusts
  • Sector
  • NEO Health Care
  • ELME Real Estate
  • Exchange
  • NEO Nasdaq
  • ELME Nasdaq
  • Market Cap
  • NEO 1.2B
  • ELME 1.3B
  • IPO Year
  • NEO 1999
  • ELME N/A
  • Fundamental
  • Price
  • NEO $8.07
  • ELME $16.07
  • Analyst Decision
  • NEO Buy
  • ELME Hold
  • Analyst Count
  • NEO 9
  • ELME 6
  • Target Price
  • NEO $13.31
  • ELME $17.80
  • AVG Volume (30 Days)
  • NEO 3.1M
  • ELME 631.3K
  • Earning Date
  • NEO 04-29-2025
  • ELME 05-01-2025
  • Dividend Yield
  • NEO N/A
  • ELME 4.50%
  • EPS Growth
  • NEO N/A
  • ELME N/A
  • EPS
  • NEO N/A
  • ELME N/A
  • Revenue
  • NEO $672,361,000.00
  • ELME $243,915,000.00
  • Revenue This Year
  • NEO $13.05
  • ELME $4.52
  • Revenue Next Year
  • NEO $11.18
  • ELME $2.58
  • P/E Ratio
  • NEO N/A
  • ELME N/A
  • Revenue Growth
  • NEO 10.10
  • ELME 5.31
  • 52 Week Low
  • NEO $6.08
  • ELME $13.95
  • 52 Week High
  • NEO $19.11
  • ELME $18.49
  • Technical
  • Relative Strength Index (RSI)
  • NEO 43.86
  • ELME 53.50
  • Support Level
  • NEO $7.66
  • ELME $15.74
  • Resistance Level
  • NEO $8.31
  • ELME $16.30
  • Average True Range (ATR)
  • NEO 0.76
  • ELME 0.39
  • MACD
  • NEO -0.01
  • ELME 0.10
  • Stochastic Oscillator
  • NEO 45.94
  • ELME 79.53

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

Share on Social Networks: